Projects per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
Mathôt R.A.A.: Population pharmacokinetic-pharmacodynamic research
Achterbergh, R., Berends, S., ten Berg - Lammers, L., Bijleveld, Y., Hodiamont, C., Preijers, T., Wind, C., Mathot, R., Fijnvandraat, K., de Haan, T., Kemper, M., Klümpen, H., van Hest, R., Kuks, P., Zwaan, C. M., Franken, L., Hazendonk, C., Masman, A., van Moort, I., Sassen, S., Schutte, L. M., Cnossen, M., van Gelder, T., Kruip, M. J. H. A., Leebeek, F. W. G. & Tibboel, D.
1/12/2012 → …
Project: Research
-
van Kaam A.H.L.C.: Neonatal pulmonology
Bijleveld, Y., Flink, R., van Houdt, C., Kraaijenga, J., Lok, I., Schouten, L., van Veen, S., de Waal, L., van Kaam, A., Onland, W. & De Jaegere, A.
1/07/2011 → …
Project: Research
Research output
-
Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Term Asphyxiated Neonates during Controlled Therapeutic Hypothermia
van der Veer, M. A. A., de Haan, T. R., Franken, L. G. W., Hodiamont, C. J., Groenendaal, F., Dijk, P. H., de Boode, W. P., Simons, S., Dijkman, K. P., van Straaten, H. L. M., Rijken, M., Cools, F., Nuytemans, D. H. G. M., van Kaam, A. H., Bijleveld, Y. A. & Mathôt, R. A. A., 17 May 2023, In: Antimicrobial agents and chemotherapy. 67, 5, p. e0170722Research output: Contribution to journal › Article › Academic › peer-review
-
Predicting treatment response to vancomycin using bacterial DNA load as a pharmacodynamic marker in premature and very low birth weight neonates: A population PKPD study
Samb, A., de Kroon, R., Dijkstra, K., van den Brand, M., Bos, M., van den Dungen, F., Veldkamp, A., Wilhelm, B., de Haan, T. R., Bijleveld, Y. A., Tutu van Furth, M., Savelkoul, P., Swart, N., Mathot, R. & van Weissenbruch, M., 2023, In: Frontiers in Pharmacology. 14, 1104482.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Therapeutic drug monitoring of amikacin in preterm and term neonates with late-onset sepsis. Can saliva samples replace plasma samples?
Samb, A., Sinkeler, F., Bijleveld, Y. A., van Kaam, A., de Haan, T. R. & Mathôt, R., Oct 2023, In: British journal of clinical pharmacology. 89, 10, p. 3195-3203 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Assay for the Determination of Total and Unbound Ciprofloxacin Concentrations in Human Plasma
de Vroom, S. L., Pistorius, M. C. M., Bijleveld, Y. A., Geerlings, S. E., Mathôt, R. A. A., van Hest, R. M. & Jager, N. G. L., 1 Aug 2022, In: Therapeutic drug monitoring. 44, 4, p. 552-557 6 p.Research output: Contribution to journal › Article › Academic › peer-review
2 Citations (Scopus) -
NOG PRECIEZER DOSEREN MET HULP VAN NIEUWE TDM-SOFTWARE
Translated title of the contribution :InsightRX Nova proves to offer Amsterdam UMC the best support: Even more precise dosing with the help of new therapeutic drug monitoring (TDM) software Research output: Contribution to journal › Article › Professional